The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Plexxikon; Rigel
Consulting or Advisory Role - Plexxikon
Final results of ENLIVEN: A global, double-blind, randomized, placebo-controlled, phase 3 study of pexidartinib in advanced tenosynovial giant cell tumor (TGCT).
 
William D. Tap
Consulting or Advisory Role - Adaptimmune; Blueprint Medicines; Daiichi Sankyo; Eisai; EMD Serono; Immune Design; Janssen; Lilly; Loxo; Novartis; Plexxikon; TRACON Pharma
 
Hans Gelderblom
Patents, Royalties, Other Intellectual Property - Amgen, Boehringer-Ingelheim, Pfizer, Novartis, Pharmamar, Daiichi, Five Prime (Inst)
Other Relationship - Daiichi Sankyo
 
Silvia Stacchiotti
Honoraria - Lilly; PharmaMar; Takeda
Consulting or Advisory Role - Bayer; Epizyme; Immune Design; Lilly; MaxiVax; PharmaMar
Research Funding - Advenchen Laboratories (Inst); Amgen (Inst); Bayer (Inst); Daiichi Sankyo (Inst); Epizyme (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - PharmaMar
 
Emanuela Palmerini
Honoraria - Amgen
Consulting or Advisory Role - Amgen; Daiichi Sankyo; Lilly
Research Funding - Daiichi Sankyo; PharmaMar (Inst)
Travel, Accommodations, Expenses - Amgen; Lilly; Takeda
 
Stefano Ferrari
Speakers' Bureau - Takeda
Research Funding - Amgen (I); Daiichi Sankyo (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - PharmaMar; Takeda
 
Jayesh Desai
Consulting or Advisory Role - Amgen; BeiGene; Bionomics; Eisai; Lilly; Novartis
Research Funding - Bionomics (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Roche (Inst)
 
Sebastian Bauer
Honoraria - Bayer; GlaxoSmithKline; Novartis; Pfizer; Pharmamar
Consulting or Advisory Role - Bayer; Blueprint Medicines; Deciphera; Lilly; Nanobiotix
Research Funding - Blueprint Medicines; Incyte (Inst); Novartis
Travel, Accommodations, Expenses - Pharmamar
 
Jean-Yves Blay
Honoraria - Bayer; GlaxoSmithKline; Lilly; Novartis; Pharmamar; Roche
Consulting or Advisory Role - Bayer; GlaxoSmithKline; Merck; Novartis; PharmaMar; Roche
Research Funding - Bayer (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pharmamar (Inst); Roche (Inst)
Other Relationship - Innate Pharma
 
Thierry Alcindor
Consulting or Advisory Role - Amgen; Astellas Pharma; Eisai; Immune Design; Lilly; Novartis Canada Pharmaceuticals Inc; Shire; Taiho Pharmaceutical
Research Funding - CytRx Corporation (Inst); Eisai (Inst); Epizyme (Inst); Lilly (Inst)
 
Kristen N. Ganjoo
Consulting or Advisory Role - Daiichi Sankyo; Immune Design; Janssen; Novartis
 
Javier Martin Broto
Consulting or Advisory Role - Bayer; Lilly; Novartis; PharmaMar
Speakers' Bureau - PharmaMar
Research Funding - PharmaMar
Travel, Accommodations, Expenses - Lilly; PharmaMar
 
Christopher W. Ryan
Consulting or Advisory Role - Eisai; Exelixis; Genentech/Roche; Novartis; Pfizer
Research Funding - Argos Therapeutics (Inst); Bristol-Myers Squibb (Inst); CytRx Corporation (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Exelixis (Inst); Genentech (Inst); GlaxoSmithKline/Novartis (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); MabVax (Inst); Merck (Inst); Morphotek (Inst); Threshold Pharmaceuticals (Inst); TRACON Pharma (Inst)
 
Dale Edward Shuster
Employment - Daiichi Sankyo
Stock and Other Ownership Interests - Daiichi Sankyo
 
Ling Zhang
Employment - Daiichi Sankyo
Stock and Other Ownership Interests - Daiichi Sankyo
 
Qiang Wang
Employment - Daiichi Sankyo
 
Henry Hsu
Employment - Plexxikon
Leadership - Plexxikon
Consulting or Advisory Role - Plexxikon
 
Paul S. Lin
Employment - Plexxikon
Leadership - Plexxikon
Patents, Royalties, Other Intellectual Property - Plexxikon
 
Sandra Tong
No Relationships to Disclose
 
Andrew J. Wagner
Consulting or Advisory Role - Five Prime Therapeutics; Lilly; Loxo
Research Funding - AADi (Inst); Celldex (Inst); Daiichi Sankyo (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Plexxikon (Inst)